ICON Medical Imaging's senior staff has been continuously active in imaging for drug development for more than 20 years, pioneering methods, procedures and regulatory guidelines over the evolution of today’s standards. This history represents hundreds of trials with imaging endpoints. However, due to the dynamic nature of drug development including regulatory guidelines, changing personnel, technology and globalization, we strongly believe that only recent experience actually matters.
ICON Medical Imaging's recent experience includes:
- Involvement in over 260 studies conducted at 1,500 centers in over 40 countries
- Maintenance of imaging review systems at FDA
- Delivery of 19+ NDA/BLAs in recent years.
ICON Medical Imaging’s use of Superior Technology, Advanced Science and Experienced People lead to the ultimate goal: results. Delivery begins with precise and thorough analysis of image data which provides our sponsors with:
- Sophisticated 3D volumes
- Measurements of metabolic changes
- Measurements of physiological changes
- Rigorous blinded read designs
- Electronic case report forms collecting data with built-in logical checks
- Access to worldwide blinded read facilities
- Stringent quality checks throughout the process
- Integrated image databases
- Permanent archives to our clients or regulatory authorities
